ES2125901T3 - Empleo de lipasas para la obtencion de medicamentos. - Google Patents

Empleo de lipasas para la obtencion de medicamentos.

Info

Publication number
ES2125901T3
ES2125901T3 ES92912628T ES92912628T ES2125901T3 ES 2125901 T3 ES2125901 T3 ES 2125901T3 ES 92912628 T ES92912628 T ES 92912628T ES 92912628 T ES92912628 T ES 92912628T ES 2125901 T3 ES2125901 T3 ES 2125901T3
Authority
ES
Spain
Prior art keywords
pct
lipases
sec
date
pub
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92912628T
Other languages
English (en)
Inventor
Reinhard Braatz
Roland Kurth
Elke Menkel-Conen
Hansjoerg Rettenmaier
Thomas Friedrich
Thomas Subkowski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF SE
Original Assignee
BASF SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BASF SE filed Critical BASF SE
Application granted granted Critical
Publication of ES2125901T3 publication Critical patent/ES2125901T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C12N9/20—Triglyceride splitting, e.g. by means of lipase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/38—Pseudomonas
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/21—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Pseudomonadaceae (F)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/916—Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)
    • G01N2333/918—Carboxylic ester hydrolases (3.1.1)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nutrition Science (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

SE DESCRIBE LA APLICACION DE UNA LIPASA BACTERIAL QUE INDICA UNA REACCION CRUCIAL INMUNOLOGICA POSITIVA CON LOS ANTICUERPOS DE LIPASA, QUE SE FORMAN A PARTIR DE MICROORGANISMOS PSEUDOMONAS SPEC DSM 6843 Y/O PSEUDOMONAS CEPACIA IAM 1057, PARA PRODUCIR MEDICAMENTOS PARA LA TERAPIA DE TRASTORNOS DEL APARATO DIGESTIVO.
ES92912628T 1991-07-01 1992-06-23 Empleo de lipasas para la obtencion de medicamentos. Expired - Lifetime ES2125901T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4121704 1991-07-01

Publications (1)

Publication Number Publication Date
ES2125901T3 true ES2125901T3 (es) 1999-03-16

Family

ID=6435147

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92912628T Expired - Lifetime ES2125901T3 (es) 1991-07-01 1992-06-23 Empleo de lipasas para la obtencion de medicamentos.

Country Status (10)

Country Link
US (3) US5489530A (es)
EP (1) EP0592478B1 (es)
JP (1) JP3593550B2 (es)
AT (1) ATE175117T1 (es)
CA (1) CA2110497C (es)
DE (1) DE59209604D1 (es)
DK (1) DK0592478T3 (es)
ES (1) ES2125901T3 (es)
MX (1) MX9203832A (es)
WO (1) WO1993000924A1 (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6140475A (en) * 1997-04-11 2000-10-31 Altus Biologics Inc. Controlled dissolution crosslinked protein crystals
US20010046493A1 (en) * 2000-02-24 2001-11-29 Alex Margolin Lipase-containing composition and methods of use thereof
DE10032058A1 (de) * 2000-07-05 2002-01-17 Basf Ag Mikrobielle Produktion von R-Phenylacetylcarbinol durch biologische Umwandlung von Benzaldehyd durch filamentöse Pilze
US20040033220A1 (en) * 2000-11-02 2004-02-19 Marcus Hartmann Use of enzymes obtained from ciliates as medicaments for promoting digestion
AU785249B2 (en) * 2002-04-24 2006-12-07 Asahi Industrial Co., Ltd. New microorganism and drainage method
US7172895B2 (en) * 2002-04-25 2007-02-06 Takuya Kitamura Microorganism and drainage method
US7142464B2 (en) * 2003-04-29 2006-11-28 Saifun Semiconductors Ltd. Apparatus and methods for multi-level sensing in a memory array
JP5032300B2 (ja) * 2004-03-22 2012-09-26 アボット プロダクツ ゲゼルシャフト ミット ベシュレンクテル ハフツング 界面活性剤を含有している、リパーゼを含有する生成物の、とりわけパンクレアチンの経口医薬組成物
UA91521C2 (ru) * 2004-10-14 2010-08-10 Элтус Фармасьютикалз Инк. Композиции, содержащие липазу, протеазу и амилазу, предназначенные для лечения недостаточности поджелудочной железы
CA2616943C (en) * 2005-07-29 2016-04-12 Solvay Pharmaceuticals Gmbh Processes for the manufacture of sterilized pancreatin powder
US9198871B2 (en) 2005-08-15 2015-12-01 Abbott Products Gmbh Delayed release pancreatin compositions
US11266607B2 (en) 2005-08-15 2022-03-08 AbbVie Pharmaceuticals GmbH Process for the manufacture and use of pancreatin micropellet cores
US20100196344A1 (en) * 2005-10-14 2010-08-05 Cystic Fibrosis Foundation Therapeutics, Inc. Compositions and methods for treating pancreatic insufficiency
WO2007053619A2 (en) * 2005-11-01 2007-05-10 Bio-Cat, Inc. A composition with a fungal (yeast) lipase and method for treating lipid malabsorption in cystic fibrous as well as people suffering from pancreatic lipase insufficiency
US10072256B2 (en) 2006-05-22 2018-09-11 Abbott Products Gmbh Process for separating and determining the viral load in a pancreatin sample
US20090130063A1 (en) * 2007-11-15 2009-05-21 Solvay Pharmaceuticals Gmbh Process for separating and determining the viral load in a pancreatin sample
CN106139132A (zh) * 2009-01-29 2016-11-23 诺尔玛克药物有限责任及股份两合公司 细菌脂肪酶药物制剂
DE102009006594A1 (de) 2009-01-29 2010-08-05 Nordmark Arzneimittel Gmbh & Co. Kg Pharmazeutisches Präparat
PL2391382T3 (pl) 2009-01-29 2014-11-28 Nordmark Arzneimittel Gmbh & Co Kg Preparat farmaceutyczny zawierający lipazę pochodzenia bakteryjnego
JP2014193909A (ja) * 2014-06-04 2014-10-09 Nordmark Arzneimittel Gmbh & Co Kg 医薬調製物
WO2016126970A1 (en) 2015-02-04 2016-08-11 Abbvie Inc. Pharmaceutical compositions and methods of use thereof to treat pancreatic enzyme insufficiency
DE102015114857A1 (de) 2015-09-04 2017-03-09 Nordmark Arzneimittel Gmbh & Co. Kg Getränk, enthaltend eine pharmazeutische Zusammensetzung
DE102015114862A1 (de) 2015-09-04 2017-03-09 Nordmark Arzneimittel Gmbh & Co. Kg Pharmazeutische Zusammensetzung, enthaltend eine bakterielle Lipase
DE102015114859A1 (de) 2015-09-04 2017-03-09 Nordmark Arzneimittel Gmbh & Co. Kg Verwendung einer pharmazeutischen Zusammensetzung, enthaltend mindestens ein Verdauungsenzym, bei der künstlichen Ernährung
AU2017221289A1 (en) 2016-02-19 2018-08-30 Basf Se Baking lipases
DE102017104480A1 (de) 2017-03-03 2018-09-06 Nordmark Arzneimittel Gmbh & Co. Kg Wässrige Lösung von Burlulipase umfassend Kalziumionen
DE102017104472A1 (de) 2017-03-03 2018-09-06 Nordmark Arzneimittel Gmbh & Co. Kg Schmelztablette enthaltend Burlulipase und daraus hergestellte pharmazeutische Zusammensetzung
WO2018209018A1 (en) 2017-05-12 2018-11-15 Basf Se Lipase enzymes
CA3076578A1 (en) 2017-10-25 2019-05-02 Basf Se Beta-amylase enzymes
WO2020185737A1 (en) 2019-03-11 2020-09-17 Basf Se Amylases and methods for making and using them

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1084431A (en) * 1964-05-06 1967-09-20 Analyses Et De Rech S Biolog M Improvements in and relating to lipases
US3431175A (en) * 1964-07-18 1969-03-04 Amano Pharma Co Ltd Method for the preparation of a lipoprotein lipase by cultivating organisms
DE1300487B (de) * 1965-08-19 1969-08-07 Hoechst Ag Verfahren zur mikrobiologischen Herstellung von Lipase
DE1642654C3 (de) * 1968-01-16 1979-11-29 Centre Europeen De Recherches Mauvernay, C.E.R.M., Riom Verfahren zur mikrobiologischen Herstellung eines stabilen gereinigten Lipase-Präparates und pharmazeutisches Mittel, welches dieses enthält
JPS4629787B1 (es) * 1968-07-02 1971-08-30
US3875007A (en) * 1972-11-03 1975-04-01 Amano Pharma Co Ltd Lipid metabolism improving and anti-atheromatic agent
US4019959A (en) * 1975-10-06 1977-04-26 Continental Oil Company Bacterial production of lipase and pyocyanine from n-paraffins
US4283494A (en) * 1978-04-26 1981-08-11 Meito Sangyo Kabushiki Kaisha Microbial lipase, process for its preparation and microbiologically pure culture therefor
GB8514708D0 (en) * 1985-06-11 1985-07-10 Unilever Plc Enzymatic detergent composition
EP0318775B1 (en) * 1987-12-03 1994-02-02 Chisso Corporation A lipase gene
JP3079276B2 (ja) * 1988-02-28 2000-08-21 天野製薬株式会社 組換え体ｄｎａ、それを含むシュードモナス属菌及びそれを用いたリパーゼの製造法
ES2059986T3 (es) * 1989-03-08 1994-11-16 Simon Lodewijk Scharpe Una composicion para el tratamiento de la insuficiencia exocrina del pancreas, y el uso de dicha composicion.

Also Published As

Publication number Publication date
EP0592478B1 (de) 1998-12-30
EP0592478A1 (de) 1994-04-20
US6030798A (en) 2000-02-29
DE59209604D1 (de) 1999-02-11
ATE175117T1 (de) 1999-01-15
JPH06509330A (ja) 1994-10-20
US5645832A (en) 1997-07-08
JP3593550B2 (ja) 2004-11-24
MX9203832A (es) 1993-01-01
US5489530A (en) 1996-02-06
CA2110497A1 (en) 1993-01-21
WO1993000924A1 (de) 1993-01-21
DK0592478T3 (da) 1999-08-30
CA2110497C (en) 2005-04-19

Similar Documents

Publication Publication Date Title
ES2125901T3 (es) Empleo de lipasas para la obtencion de medicamentos.
KR850008282A (ko) 그람음성균상의 혈청형 리포다당류 결정인자에 대한 인체 단크론(monoclonal)항체와 그 제조방법
ATE243735T1 (de) Alkalische lipase
MX9306220A (es) Ptp 1d: una proteina tirosina fosfatasa novedosa.
ID24398A (id) Metode untuk menghasilkan asam l-amino
FI964845A0 (fi) CD44v6:n vastaiset monoklonaaliset vasta-aineet
BR9610390A (pt) O uso de uma tienotriazolodiazepina para aumentar os níveis da apoliproteína a-i
YU47886B (sh) Postupak za dobijanje novih sojeva s. avermitilis
ES2191066T3 (es) Preparacion enantioselectiva de sulfoxidos farmaceuticamente activos por biooxidacion.
AU6357596A (en) Pharmaceutical and diet formulations for the prophylaxis and treatment of gastrointestinal disorders
AU571495B2 (en) Mucoid exopolysaccharide vaccine against pseudomonas aeruginosa
UA50708C2 (uk) Моноклональне антитіло, яке має здатність розпізнавати антиген, який викликає апоптоз мієлоїдних клітин, фрагмент f(ab)2 моноклонального антитіла, гібридома ferm bp-4382
ES2035260T3 (es) Cepa de microorganismos con actividad antimicrobiana.
HUP0001014A2 (hu) Gasztrointesztinális lipáz inhibitorok felhasználása
NO159608C (no) Fremgangsm te for fremstilling av 6-hydroksynikotin
MY129859A (en) Bacterial strains of the bacterium bacillus thuringiensis and uses therefor
PT946730E (pt) Mutantes de toxina estreptococica c e metodos de utilizacao
DE3881531D1 (de) Verwendung von gamma-glutamyl-transpeptidase.
NO180642C (no) Alkalipullulanase og renisolert kultur av Bacillus sp. mikroorganisme som produserer denne
FR2698879B1 (fr) gellules modifiées au niveau du catabolisme de la bétaïne, préparation et utilisations, notamment pour la production de métabolites ou d'enzymes.
ES2103575T3 (es) Procedimiento para la preparacion de 9-(2-hidroxi)-etoximetil-guanina.
ES465339A1 (es) Procedimiento para la obtencion de inhibidores para glicosi-dohidrolasas.
ES8707114A1 (es) Procedimiento para la obtencion de un anticuerpo monoclonal anti-alfa-amilasa
FI944563A (fi) Mikro-organismeja, valmistusmenetelmä ja käyttö
AU6176596A (en) Compositions exhibiting adp-ribosyltransferase activity and methods for the preparation and use thereof

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 592478

Country of ref document: ES